MCM
BIIB icon

Millie Capital Management’s Biogen BIIB Stock Holding History

Millie Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$360K Buy
+1,130
New +$363K 0.3% 53

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millie Capital Management's BIIB Position: Q4 2017 in Review

Millie Capital Management opened a new position in Biogen (BIIB) in Q4 2017: 1,130 shares worth $360K. The stake represents 0.3% of the portfolio and ranks #53 among its holdings.

1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Millie Capital Management held 1,130 shares of Biogen worth $360K as of Q4 2017.
  • Biogen was a new Millie Capital Management position in Q4 2017.
  • Biogen made up 0.3% of Millie Capital Management's portfolio in Q4 2017, its #53 holding.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Millie Capital Management's 13F filing for Q4 2017, filed 7 Feb 2018.